CD36 is a novel and potential anti-fibrogenic target in albumin-induced renal proximal tubule fibrosis

Journal of Cellular Biochemistry

Volumn 101, Issue 3, 2007, Pages 735-744

  Yang, Yu Lin ^a   Lin, Shyh Horng ^a   Chuang, Lea Yea ^b   Guh, Jinn Yuh ^b   Liao, Tung Nan ^a   Lee, Tao Chen ^c   Chang, Wen Teng ^a   Chang, Fang Rong ^b   Hung, Min Yuan ^a   Chiang, Tai An ^b   Hung, Chien Ya ^a  

^a CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

CD36; Diabetic nephropathy; Fibronectin; Fibrosis; TGF beta

Indexed keywords

ALBUMIN; CD36 PROTEIN; FIBRONECTIN; PROTEIN; PROTEIN DERIVATIVE; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL SIZE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GROWTH INHIBITION; HYPERTROPHY; KIDNEY CELL; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; SWINE; UPREGULATION; WESTERN BLOTTING;

ALBUMINS; ANIMALS; ANTIGENS, CD36; BLOTTING, WESTERN; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRONECTINS; FIBROSIS; HYPERTROPHY; KIDNEY TUBULES, PROXIMAL; MODELS, BIOLOGICAL; RNA, SMALL INTERFERING; SWINE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34247869658     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21236     Document Type: Article

References (28)

1. Asch AS, Silbiger S, Heimer E, Nachman RL. 1992. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem Biophys Res Commun 182(3):1208-1217.
2. Bastian M, Steiner M, Schuff-Werner P. 2005. Expression of thrombospondin-1 in prostate-derived cell lines. Int J Mol Med 15(1):49-56.
3. Burton C, Harris KPG. 1996. The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 27: 765-775.
4. Burton CJ, Combe C, Walls J, Harris KPG. 1999. Secretion of chemokines and cytokines by human tubular epithelial cells in response to proteins. Nephrol Dial Transplant 14:2628-2633.
5. Chuang LY, Guh JY, Liu SF, Hung MY, Liao TN, Chiang TA, Huang JS, Huang YL, Lin CF, Yang YL. 2003. Regulation of type II transforming-growth-factor-beta receptors by protein kinase C iota. Biochem J 375(Pt 2): 385-393.
6. D'Amico G, Bazzi C. 2003. Pathophysiology of proteinuria. Kidney Int 63:809-825.
7. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL. 2000. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest 105:1049-1056.
8. Febbraio M, Hajjar DP, Silverstein RL. 2001. CD36: A class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J Clin Invest 108:785-791.
9. Griffin E, Re A, Hamel N, Fu C, Bush H. 2001. A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation. Nat Med 7: 840-846.
10. Hawighorst T, Oura H, Streit M, Janes L, Nguyen L, Brown LF, Oliver G, Jackson DG, Detmar M. 2002. Thrombospondin-1 selectively inhibits early-stage carcinogenesis and angiogenesis but not tumor lymphangiogenesis and lymphatic metastasis in transgenic mice. Oncogene 21(52):7945-7956.
11. Lagadec P, Dejoux O, Ticchioni M, Cottrez F, Johansen M, Brown EJ, Bernard A. 2003. Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow. Blood 101(12):4836-4843.
12. Li K, Yang M, Yuen PM, Chik KW, Li CK, Shing MM, Lam HK, Fok TF. 2003. Thrombospondin-1 induces apoptosis in primary leukemia and cell lines mediated by CD36 and Caspase-3. Int J Mol Med 12(6):995-1001.
13. Liu HC, Liao TN, Lee TC, Chuang LY, Guh JY, Liu SF, Hu MS, Yang Y-L, Lin SH, Hung MY, Huang JS, Hung TJ, Chen CD, Chiang TA, Chan JY, Chen SY, Yang Y-L. 2006. Albumin induces cellular fibrosis by upregulating transforming growth factor-beta ligand and its receptors in renal distal tubule cells. J Cell Biochem 97(5):956-968.
14. Nenigni A, Zoja C, Remuzzi G. 1995. The renal toxicity of sustained glomerular protein traffic. Lab Invest 73(4): 461-468.
15. Qi W, Chen X, Twigg S, Polhill TS, Gilbert RE, Pollock CA. 2006. Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells. Kidney Int 69(6):989-995.
16. Ruggenenti P, Perna A, Mosconi L. 1998. Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Kidney Int 53:1209-1216.
17. Steinke JM, Sinaiko AR, Kramer MS, Suissa S, Chavers BM, Mauer M. 2005. International Diabetic Nephopathy Study Group. The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes 54(7):2164-2171.
18. Susztak K, Bottinger E, Novetsky A, Liang D, Zhu Y. 2004. Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 53: 784-794.
19. Susztak K, Ciccone E, McCue P, Sharma K, Bottinger EP. 2005. Multiple metabolic hits converge on CD36 as novel mediator of tubular epithelial apoptosis in diabetic nephropathy. PLoS Med 2(2):e45.
20. Tan X, Li Y, Liu Y. 2006. Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol. Nov 2; [PMID: 17082242, Epub ahead of print]
21. Tang S, Leung JCK, Abe K, Chan KW. 2003. Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 11:515-527.
22. Weigert C, Brodbeck K, Brosius FC III, Huber M, Lehmann R, Friess U, Facchin S, Aulwurm S, Haring HU, Schleicher ED, Heilig CW. 2003. Evidence for a novel TGF-beta1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters. Diabetes 52(2):527-535.
23. Yang YL, Guh JY, Yang ML, Lai YH, Tsai JH, Hung WC, Chang CC, Chuang LY. 1998. Interaction between high glucose and transforming growth factor-b in cell cycle protein regulations in MDCK cells. J Am Soc Nephrol 9: 182-193.
24. Yang YL, Chuang LY, Guh JY, Liu SF, Hung MY, Liao TN, Huang YL. 2004. Thrombospondin-1 mediates distal tubule hypertrophy induced by glycated albumin. Biochem J 379(Pt 1):89-97.
25. Yard BA, Chorianopoulos E, Herr D, van der Woude FJ. 2001. Regulation of endothelin-1 and transforming growth factor-1 production in cultured proximal tubular cells by albumin and heparan sulphate glycosaminoglycans. Nephrol Dial Transplant 16:1769-1775.
26. Yehualaeshet T, O'Connor R, Green-Johnson J, Mai S, Silverstein R, Murphy-Ullrich JE, Khalil N. 1999. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am J Pathol 155(3):841-851.
27. Yehualaeshet T, O'Connor R, Begleiter A, Murphy-Ullrich JE, Silverstein R, Khalil N. 2000. A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat. Am J Respir Cell Mol Biol 23(2):204-212.
28. Zoja C, Donadelli R, Colleoni S. 1998. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-B activation. Kidney Int 53:1608-1615.